FDCDDQ
CMPX icon

Federation des caisses Desjardins du Quebec’s Compass Therapeutics CMPX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76K Buy
4,000
+3,000
+300% +$8.86K ﹤0.01% 2449
2026
Q1 		$5.29K Buy
1,000
+500
+100% +$2.89K ﹤0.01% 2485
2025
Q4 		$2.69K Buy
+500
New +$2.31K ﹤0.01% 2567

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CMPX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Compass Therapeutics (CMPX) stake by 300% in Q2 2026, buying an estimated $8.86K and bringing the position to 4,000 shares worth $8.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Federation des caisses Desjardins du Quebec first reported a position in CMPX in Q4 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 4,000 shares of Compass Therapeutics worth $8.76K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 3,000 Compass Therapeutics shares in Q2 2026, an estimated $8.86K.
  • Compass Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2449 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Compass Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.